Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

202429 citationsJournal Article

Authors

Our results identify MIR652-3p as a potential biomarker and as a driver of cell and non-cell-autonomous mechanisms of resistance to regorafenib.

Good health and well-being

Published in: Clinical Cancer Research

Volume 30, Issue 10, pp. 2140-2159

Field-Weighted Citation Impact: 8.20